The flu can also cause a general feeling of fatigue or malaise, Ray says, as well as gastrointestinal issues like diarrhea ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Having the flu is a lousy experience, regardless of the type you have. While news of a rough flu season ahead (spurred by subclade K) continues to make headlines, there are two main types of flu, A ...

A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

LOS ANGELES (KABC) -- Sick patients are flooding doctor's offices as cases of the flu surge across Southern California. This year, a particularly potent B strain of the virus seems to be causing many ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

The CDC launched National Influenza Vaccination week to remind people it’s not too late to get vaccinated. The campaign ...

The vaccine has been approved by HSA for use in individuals aged 2 to 49 years. Read more at straitstimes.com. Read more at straitstimes.com.